Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
QuintilesIMS
Chubb
Cantor Fitzgerald
Moodys
Medtronic
Cerilliant
Chinese Patent Office
AstraZeneca

Generated: May 23, 2018

DrugPatentWatch Database Preview

GLUTETHIMIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Summary for GLUTETHIMIDE
Drug patent expirations by year for GLUTETHIMIDE
Medical Subject Heading (MeSH) Categories for GLUTETHIMIDE
Synonyms for GLUTETHIMIDE
.alpha.-Ethyl-.alpha.-phenylglutarimide
.alpha.-Phenyl-.alpha.-ethylglutaric acid imide
.alpha.-Phenyl-.alpha.-ethylglutarimide
056G091
2-Ethyl-2-phenylglutarimide
2-Phenyl-2-ethylglutaric acid imide
2, 3-ethyl-3-phenyl-
2,6-Piperidinedione, 3-ethyl-3-phenyl-
3-Ethyl-3-phenyl-2,6-diketopiperidine
3-Ethyl-3-phenyl-2,6-dioxopiperidine
3-Ethyl-3-phenyl-2,6-piperidinedione
3-Ethyl-3-phenyl-piperidine-2,6-dione
3-ethyl-3-phenylpiperidine-2,6-dione
3-ethyl-6-hydroxy-3-phenyl-2,3,4,5-tetrahydropyridin-2-one
3-Phenyl-3-ethyl-2,6-diketopiperidine
3-Phenyl-3-ethyl-2,6-dioxopiperidine
77-21-4
AC-16077
AC1L1G1N
AC1Q2SPK
AI3-50601
AKOS015897742
Alfimid
alpha-Ethyl-alpha-phenylglutarimide
alpha-Phenyl-alpha-ethylglutaric acid imide
alpha-Phenyl-alpha-ethylglutarimide
AN-25304
API0004772
C07489
CAS-77-21-4
CC 11511
CHEBI:5439
CHEMBL1102
D00532
D0Z9NZ
DB01437
DEA No. 2550
dl-Glutethimide
Doriden
Doriden (TN)
Doriden-sed
Doriden|||Noxiron|||2-Ethyl-2-phenylglutarimide
Dorimide
DSSTox_CID_3102
DSSTox_GSID_23102
DSSTox_RID_76876
DTXSID1023102
EINECS 201-012-0
Elrodorm
FT-0657714
Gimid
Glimid
Glutarimide, 2-ethyl-2-phenyl-
Glutathimid
Glutethamide
Glutethimid
Glutethimide (JAN/INN)
Glutethimide [INN:BAN]
Glutethimidum
Glutethimidum [INN-Latin]
Glutetimid
Glutetimida
Glutetimida [INN-Spanish]
Glutetimide
Glutetimide [DCIT]
Glutetimidu
Glutetimidu [Polish]
Gluthetimide
GTPL7192
HE046986
HE387688
HSDB 3088
JMBQKKAJIKAWKF-UHFFFAOYSA-N
LS-72074
LT00114358
NCGC00159407-02
NCGC00159407-03
NCGC00159407-04
Noxiron
Noxyron
NSC 95239
NSC-95239
NSC95239
Ondasil
Phenyl-aethyl-glutarsaeureimid
Phenyl-aethyl-glutarsaeureimid [German]
Rigenox
Sarodormin
SCHEMBL113708
Tox21_111641
Tox21_111641_1
WLN: T6VMVTJ D2 DR

US Patents and Regulatory Information for GLUTETHIMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Halsey GLUTETHIMIDE glutethimide TABLET;ORAL 089458-001 Oct 10, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Vitarine GLUTETHIMIDE glutethimide TABLET;ORAL 087297-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lannett GLUTETHIMIDE glutethimide TABLET;ORAL 085571-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs GLUTETHIMIDE glutethimide TABLET;ORAL 084362-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Deloitte
Harvard Business School
Julphar
Federal Trade Commission
QuintilesIMS
Teva
Fuji
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.